Persons entitled
- Kreos Capital V (Expert Fund) L.P.
Brief description
1) glycolipid containing compositions for use in the treatment of tumours with patent/application number wo 2015/170121 -. pct/GB2015/051368. 2) therapeutic compositions and methods of use for treating cancer with patent/application number WO2016/162675 -pct/GB2016/050973. And those assets listed in schedule a of the instrument.
Contains fixed charge.